Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

NDUFS2

Introduction

NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (NDUFS2) also known as NADH-ubiquinone oxidoreductase 49 kDa subunit is an enzyme that in humans is encoded by the NDUFS2 gene.[1][2] The protein encoded by this gene is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (complex I). Mutations in this gene are associated with mitochondrial complex I deficiency.[3]

Structure

Structure

NDUFS2 is located on the q arm of chromosome 1 in position 23.3 and has 15 exons.[3] The NDUFS2 gene produces a 52.5 kDa protein composed of 463 amino acids.[4][5] NDUFS2, the protein encoded by this gene, is a member of the complex I 49 kDa subunit family. It is a peripheral membrane protein on the matrix side of the inner mitochondrial membrane. It contains a cofactor binding site for a [4Fe-4S] cluster, a transit peptide, 5 turns, 11 beta strands, and 18 alpha helixes.[6][7] Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[3]

Function

Function

Mitochondrial complex I is the first multimeric complex of the respiratory chain that catalyzes the NADH oxidation with concomitant ubiquinone reduction and proton ejection out of the mitochondria. Mammalian mitochondrial complex I is an assembly of at least 43 different subunits. Seven of the subunits are encoded by the mitochondrial genome; the remainder are the products of nuclear genes. The iron-sulfur protein (IP) fraction of complex I is made up of 7 subunits, including NDUFS2.[3] Dimethylation at Arg-118 by NDUFAF7 takes place after NDUFS2 assembles into the complex I, leading to the stabilization of the early intermediate complex.[8][9][6][7]

Clinical significance

Clinical significance

Mutations in the NDUFS2 gene are associated with Mitochondrial Complex I Deficiency, which is autosomal recessive. This deficiency is the most common enzymatic defect of the oxidative phosphorylation disorders.[10][11] Mitochondrial complex I deficiency shows extreme genetic heterogeneity and can be caused by mutation in nuclear-encoded genes or in mitochondrial-encoded genes. There are no obvious genotype-phenotype correlations, and inference of the underlying basis from the clinical or biochemical presentation is difficult, if not impossible.[12] However, the majority of cases are caused by mutations in nuclear-encoded genes.[13][14] It causes a wide range of clinical disorders, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, nonspecific encephalopathy, hypertrophic cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease.[15]

Interactions

Interactions

NDUFS2 has been shown to have 121 binary protein-protein interactions including 112 co-complex interactions. NDUFS2 appears to interact with NDUFS3, MKLN1, EGR2, HMOX2, CENPU, and TNFRSF14.[16]

See also

See also

References

References

  1. ↑ Fearnley IM, Finel M, Skehel JM, Walker JE (September 1991). “NADH:ubiquinone oxidoreductase from bovine heart mitochondria. cDNA sequences of the import precursors of the nuclear-encoded 39 kDa and 42 kDa subunits”. The Biochemical Journal. 278. 278 ( Pt 3) (3): 821–9. doi:10.1042/bj2780821. PMCΒ 1151420. PMIDΒ 1832859.
  2. ↑ Procaccio V, de Sury R, Martinez P, Depetris D, Rabilloud T, Soularue P, Lunardi J, Issartel J (June 1998). “Mapping to 1q23 of the human gene (NDUFS2) encoding the 49-kDa subunit of the mitochondrial respiratory Complex I and immunodetection of the mature protein in mitochondria”. Mammalian Genome. 9 (6): 482–4. doi:10.1007/s003359900803. PMIDΒ 9585441.
  3. ↑ 3.0 3.1 3.2 3.3 “Entrez Gene: NDUFS2 NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase)”. This article incorporates text from this source, which is in the public domain.
  4. ↑ Yao, Daniel. “Cardiac Organellar Protein Atlas Knowledgebase (COPaKB) β€”β€” Protein Information”. amino.heartproteome.org. Retrieved 2018-08-27.
  5. ↑ Zong NC, Li H, Li H, Lam MP, Jimenez RC, Kim CS, Deng N, Kim AK, Choi JH, Zelaya I, Liem D, Meyer D, Odeberg J, Fang C, Lu HJ, Xu T, Weiss J, Duan H, Uhlen M, Yates JR, Apweiler R, Ge J, Hermjakob H, Ping P (October 2013). “Integration of cardiac proteome biology and medicine by a specialized knowledgebase”. Circulation Research. 113 (9): 1043–53. doi:10.1161/CIRCRESAHA.113.301151. PMCΒ 4076475. PMIDΒ 23965338.
  6. ↑ 6.0 6.1 “NDUFS2 – NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial precursor – Homo sapiens (Human) – NDUFS2 gene & protein”. www.uniprot.org. Retrieved 2018-08-27.File:CC-BY-icon-80×15.pngΒ This article incorporates text available under the CC BY 4.0 license.
  7. ↑ 7.0 7.1 “UniProt: the universal protein knowledgebase”. Nucleic Acids Research. 45 (D1): D158–D169. January 2017. doi:10.1093/nar/gkw1099. PMCΒ 5210571. PMIDΒ 27899622.
  8. ↑ Rhein VF, Carroll J, Ding S, Fearnley IM, Walker JE (November 2013). “NDUFAF7 methylates arginine 85 in the NDUFS2 subunit of human complex I”. The Journal of Biological Chemistry. 288 (46): 33016–26. doi:10.1074/jbc.M113.518803. PMCΒ 3829151. PMIDΒ 24089531.
  9. ↑ Zurita RendΓ³n O, Silva Neiva L, Sasarman F, Shoubridge EA (October 2014). “The arginine methyltransferase NDUFAF7 is essential for complex I assembly and early vertebrate embryogenesis”. Human Molecular Genetics. 23 (19): 5159–70. doi:10.1093/hmg/ddu239. PMCΒ 4159157. PMIDΒ 24838397.
  10. ↑ Kirby DM, Salemi R, Sugiana C, Ohtake A, Parry L, Bell KM, Kirk EP, Boneh A, Taylor RW, Dahl HH, Ryan MT, Thorburn DR (September 2004). “NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency”. The Journal of Clinical Investigation. 114 (6): 837–45. doi:10.1172/JCI20683. PMCΒ 516258. PMIDΒ 15372108.
  11. ↑ McFarland R, Kirby DM, Fowler KJ, Ohtake A, Ryan MT, Amor DJ, Fletcher JM, Dixon JW, Collins FA, Turnbull DM, Taylor RW, Thorburn DR (January 2004). “De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency”. Annals of Neurology. 55 (1): 58–64. doi:10.1002/ana.10787. PMIDΒ 14705112.
  12. ↑ Haack TB, Haberberger B, Frisch EM, Wieland T, Iuso A, Gorza M, Strecker V, Graf E, Mayr JA, Herberg U, Hennermann JB, Klopstock T, Kuhn KA, Ahting U, Sperl W, Wilichowski E, Hoffmann GF, Tesarova M, Hansikova H, Zeman J, Plecko B, Zeviani M, Wittig I, Strom TM, Schuelke M, Freisinger P, Meitinger T, Prokisch H (April 2012). “Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing”. Journal of Medical Genetics. 49 (4): 277–83. doi:10.1136/jmedgenet-2012-100846. PMIDΒ 22499348.
  13. ↑ Loeffen JL, Smeitink JA, Trijbels JM, Janssen AJ, Triepels RH, Sengers RC, van den Heuvel LP (2000). “Isolated complex I deficiency in children: clinical, biochemical and genetic aspects”. Human Mutation. 15 (2): 123–34. doi:10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P. PMIDΒ 10649489.
  14. ↑ Triepels RH, Van Den Heuvel LP, Trijbels JM, Smeitink JA (2001). “Respiratory chain complex I deficiency”. American Journal of Medical Genetics. 106 (1): 37–45. doi:10.1002/ajmg.1397. PMIDΒ 11579423.
  15. ↑ Robinson BH (May 1998). “Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect”. Biochimica et Biophysica Acta. 1364 (2): 271–86. doi:10.1016/s0005-2728(98)00033-4. PMIDΒ 9593934.
  16. ↑ “121 binary interactions found for search term NDUFS2”. IntAct Molecular Interaction Database. EMBL-EBI. Retrieved 2018-08-27.
Further reading

Further reading

  • Bar-Meir M, Elpeleg ON, Saada A (December 2001). “Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency”. The Journal of Pediatrics. 139 (6): 868–70. doi:10.1067/mpd.2001.118885. PMIDΒ 11743516.
  • Maruyama K, Sugano S (January 1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMIDΒ 8125298.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMIDΒ 9373149.
  • Loeffen J, van den Heuvel L, Smeets R, Triepels R, Sengers R, Trijbels F, Smeitink J (June 1998). “cDNA sequence and chromosomal localization of the remaining three human nuclear encoded iron sulphur protein (IP) subunits of complex I: the human IP fraction is completed”. Biochemical and Biophysical Research Communications. 247 (3): 751–8. doi:10.1006/bbrc.1998.8882. PMIDΒ 9647766.
  • Loeffen JL, Triepels RH, van den Heuvel LP, Schuelke M, Buskens CA, Smeets RJ, Trijbels JM, Smeitink JA (December 1998). “cDNA of eight nuclear encoded subunits of NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed”. Biochemical and Biophysical Research Communications. 253 (2): 415–22. doi:10.1006/bbrc.1998.9786. PMIDΒ 9878551.
  • Triepels RH, Hanson BJ, van den Heuvel LP, Sundell L, Marusich MF, Smeitink JA, Capaldi RA (March 2001). “Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns”. The Journal of Biological Chemistry. 276 (12): 8892–7. doi:10.1074/jbc.M009903200. PMIDΒ 11112787.
  • Loeffen J, Elpeleg O, Smeitink J, Smeets R, StΓΆckler-Ipsiroglu S, Mandel H, Sengers R, Trijbels F, van den Heuvel L (February 2001). “Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy”. Annals of Neurology. 49 (2): 195–201. doi:10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M. PMIDΒ 11220739.
  • Murray J, Taylor SW, Zhang B, Ghosh SS, Capaldi RA (September 2003). “Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry”. The Journal of Biological Chemistry. 278 (39): 37223–30. doi:10.1074/jbc.M305694200. PMIDΒ 12857734.
  • Ugalde C, Janssen RJ, van den Heuvel LP, Smeitink JA, Nijtmans LG (March 2004). “Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency”. Human Molecular Genetics. 13 (6): 659–67. doi:10.1093/hmg/ddh071. PMIDΒ 14749350.
  • Bourges I, Ramus C, Mousson de Camaret B, Beugnot R, Remacle C, Cardol P, Hofhaus G, Issartel JP (November 2004). “Structural organization of mitochondrial human complex I: role of the ND4 and ND5 mitochondria-encoded subunits and interaction with prohibitin”. The Biochemical Journal. 383 (Pt. 3): 491–9. doi:10.1042/BJ20040256. PMCΒ 1133742. PMIDΒ 15250827.
  • Ma J, Dempsey AA, Stamatiou D, Marshall KW, Liew CC (March 2007). “Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects”. Atherosclerosis. 191 (1): 63–72. doi:10.1016/j.atherosclerosis.2006.05.032. PMIDΒ 16806233.
  • Vogel RO, Dieteren CE, van den Heuvel LP, Willems PH, Smeitink JA, Koopman WJ, Nijtmans LG (March 2007). “Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits”. The Journal of Biological Chemistry. 282 (10): 7582–90. doi:10.1074/jbc.M609410200. PMIDΒ 17209039.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.